Opioid activity of sendide, a tachykinin NK1 receptor antagonist

European Journal of Pharmacology

Volumn 369, Issue 3, 1999, Pages 261-266

  Sakurada, Tsukasa ^a   Yuhki, Masayuki ^b   Inoue, Makoto ^b   Sakurada, Chikai ^a   Tan No, Koichi ^b   Ohba, Masataka ^c   Kisara, Kensuke ^b   Sakurada, Shinobu ^b  

^a DAIICHI UNIVERSITY OF PHARMACY   (Japan)

^b Department of Pharmacology Tohoku Pharmaceutical U ^*  (Japan)

^c Research Center   (Japan)

Author keywords

Mouse; Opioid activity; Scratching, biting and licking; Sendide; Spinal cord; Tachykinin NK1 receptor antagonist

Indexed keywords

BOMBESIN; ELEDOISIN; N METHYL DEXTRO ASPARTIC ACID; NALOXONE; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR AGONIST; NEUROKININ 3 RECEPTOR AGONIST; NEUROKININ A; NEUROKININ B; OPIATE; OPIATE AGONIST; PHYSALAEMIN; SENDIDE; SEPTIDE; SOMATOSTATIN; SUBSTANCE P DERIVATIVE; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BITE; CONTROLLED STUDY; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LICKING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; SPINAL CORD;

EID: 0032942522     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00078-3     Document Type: Article

References (44)

1. Aanonsen L.M., Wilcox G.L. Phencyclidine selectively blocks a spinal action of N-methyl-D-aspartate in mice. Neurosci. Lett. 67:1986;191-197.
2. Chen Z., Engberg G., Hedner T., Hedner J. Antagonistic effects of somatostatin and substance P on respiratory regulation in the rat ventrolateral medulla oblongata. Brain Res. 556:1991;13-20.
3. Doi T., Jurna I. Intrathecal substance P depresses the tail flick response: antagonism by naloxone. Naunyn-Schmiedeberg's Arch. Pharmacol. 317:1981;135-139.
4. Fleetwood-Walker S.M., Mitchell R., Hope P.J., El-Yassir N., Molony V., Bladon C.M. The involvement of neurokinin receptor subtypes in somatosensory processing in the superficial dorsal horn of the cat. Brain Res. 519:1990;169-182.
5. Frederickson R.C.A., Burgis V., Harrell C.E., Edwards J.D. Dual actions of substance P on nociception: possible role of endogenous opioids. Science. 199:1978;1359-1362.
6. Frenk H., Bossut D., Urca G., Mayer D.J. Is substance P a primary afferent transmitter for nociceptive input? I. Analysis of pain-related behaviors resulting from intrathecal administration of substance P and 6 excitatory compounds. Brain Res. 455:1988;223-231.
7. Guard S., Watson S.P. Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem. Int. 18:1991;149-165.
8. Hayes A., Tyres M. Effects of intrathecal and intracerebroventricular injections of substance P on nociception in the rat and mouse. Br. J. Pharmacol. 66:1979;488P.
9. Helke C.J., Krause J.E., Mantyh P.W., Couture R., Bannon M.J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J. 4:1990;1606-1615.
10. Hershey A.D., Krause J.E. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science. 247:1990;958-962.
11. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
12. Hylden J.L.K., Wilcox G.L. Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res. 217:1981;212-215.
13. Hylden J.L.K., Wilcox G.L. Intrathecal opioids block a spinal action of substance P in mice: functional importance of both μ- and δ-receptors. Eur. J. Pharmacol. 86:1982;95-98.
14. Johnston P.A., Chahl L.A. Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs. Naunyn-Schmiedeberg's Arch. Pharmacol. 343:1991;283-288.
15. Kream R.M., Kato T., Shimonaka H., Marchand J.E., Wurm W.H. Substance P markedly potentiates the antinociceptive effects of morphine sulfate administered at the spinal level. Proc. Natl. Acad. Sci. USA. 90:1993;3564-3568.
16. Kudlacz E.M., Shatzer S.A., Knippenberg R.W., Logan D.E., Poirot M., Van Giersbergen P.L.M., Burkholder T.P. In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist. J. Pharmacol. Exp. Ther. 277:1996;840-851.
17. Larson A.A. Desensitization to intrathecal substance P in mice: possible involvement of opioids. Pain. 32:1988;367-374.
18. Longmore J., Swain C.J., Hill R.G. Neurokinin receptors. Drug News Perspect. 8:1995;5-23.
19. Masu Y., Nakayama K., Tamaki H., Harada Y., Kuno M., Nakanishi S. cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature. 329:1987;836-838.
20. 1) receptor antagonist. Science. 251:1991;437-439.
21. 2 receptor selectivity. J. Pharmacol. Exp. Ther. 262:1992;398-402.
22. 2 receptor antagonist, on airway constriction and airway edema induced by tachykinins and sensory nerve stimulation in guinea-pigs. J. Pharmacol. Exp. Ther. 262:1992;403-408.
23. Post C., Folkers K. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice. Eur. J. Pharmacol. 113:1985;335-343.
24. Quirion R., Dam T.V. Multiple neurokinin receptors: recent developments. Regul. Pept. 22:1988;18-25.
25. Regoli D., Drapeau G., Dion S., Couture R. New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol. Sci. 9:1988;290-295.
26. 2 receptor antagonist. Eur. J. Pharmacol. 294:1995;677-684.
27. Sakurada T., Kuwahara H., Sakurada S., Kisara K., Ohba M., Munekata E. Behavioural assessment as substance P antagonists in mice. Neuropeptides. 9:1987;197-206.
28. Sakurada T., Takahashi K., Sakurada S., Kisara K., Folkesson R., Terenius L. Enkephalins interact with substance P-induced aversive behaviour in mice. Brain Res. 442:1988;191-194.
29. Sakurada T., Yamada T., Sakurada S., Kisara K., Ohba M. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice. Eur. J. Pharmacol. 174:1989;153-160.
30. Sakurada T., Manome Y., Tan-No K., Sakurada S., Kisara K. The effect of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice. Br. J. Pharmacol. 101:1990;307-310.
31. Sakurada, T., Katsumata, K., Uchiumi, H., Manome, Y., Tan-No, K., Sakurada, S., Kawamura, S., Ando, R., Kisara, K., 1992a. Spantide-induced antinociception in the mouse formalin test. In: Inoki, R., Shigenaga, Y., Tohyama, M., (Eds.), Processing and Inhibition of Nociceptive Information, Excerpta Medica, pp. 227-230.
32. Sakurada T., Manome Y., Katsumata K., Uchiumi H., Tan-No K., Sakurada S., Kisara K. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 346:1992;69-75.
33. Sakurada T., Manome Y., Tan-No K., Sakurada S., Kisara K., Ohba M., Terenius L. A selective and extremely potent antagonist of the neurokinin-1 receptor. Brain Res. 593:1992;319-322.
34. Sakurada T., Manome Y., Katsumata K., Tan-No K., Sakurada S., Ohba M., Kisara K. Comparison of antagonistic effects of sendide and CP-96,345 on the spinally-mediated behavioural response in mice. Eur. J. Pharmacol. 261:1994;85-90.
35. Sakurada T., Sakurada C., Tan-No K., Kisara K. Neurokinin receptor antagonists. Therapeutic potential in the treatment of pain syndromes. CNS Drugs. 8:1997;436-447.
36. Shigemoto R., Yokota Y., Tsuchida K., Nakanishi S. Cloning and expression of a rat neuromedin K receptor cDNA. J. Biol. Chem. 265:1990;623-628.
37. Skilling S.R., Smullin D.H., Larson A.A. Differential effects of C- and N-terminals of SP on the apparent release of amino acids from the rat dorsal spinal cord. J. Neurosci. 10:1990;1309-1318.
38. 1) receptor. Science. 251:1991;435-437.
39. Takahashi K., Sakurada T., Sakurada S., Kuwahara H., Yonezawa A., Ando R., Kisara K. Behavioural characterization of substance P-induced nociceptive response in mice. Neuropharmacology. 26:1987;1289-1293.
40. Tan-No K., Sakurada T., Yamada T., Sakurada S., Kisara K. Involvement of opioid receptors in the antinociception produced by intracerebroventricularly administered spantide in mice. Neuropeptides. 29:1995;293-299.
41. Urban L., Randic M. Slow excitatory transmission in the rat dorsal horn: possible mediation by peptides. Brain Res. 290:1984;241-336.
42. Vaught J.L., Post J., Jacoby H.I., Wright D. Tachykinin-like central activity of neuromedin K in mice. Eur. J. Pharmacol. 103:1984;355-357.
43. Willcockson W.S., Chung J.M., Hori Y., Lee K.H., Willis W.D. Effects of iontophoretically released peptides on primate spinothalamic tract cells. J. Neurosci. 4:1984;741-750.
44. Yokota Y., Sasai Y., Tanaka K., Fujiwara T., Tsuchida K., Shigemoto R., Kakizuka A., Ohkubo H., Nakanishi S. Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 264:1989;17649-17652.